Biosergen AB Statistics

Total Valuation

Biosergen AB has a market cap or net worth of SEK 86.88 million. The enterprise value is 71.52 million.

Market Cap	86.88M
Enterprise Value	71.52M

Important Dates

The next confirmed earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Biosergen AB has 2.35 million shares outstanding. The number of shares has decreased by -2.13% in one year.

Current Share Class	2.35M
Shares Outstanding	2.35M
Shares Change (YoY)	-2.13%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	42.01%
Float	851,564

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	10.70
P/TBV Ratio	10.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.75
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio	1.95
Quick Ratio	1.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -144.93% and return on invested capital (ROIC) is -90.67%.

Return on Equity (ROE)	-144.93%
Return on Assets (ROA)	-68.46%
Return on Invested Capital (ROIC)	-90.67%
Return on Capital Employed (ROCE)	-389.70%
Weighted Average Cost of Capital (WACC)	5.83%
Revenue Per Employee	n/a
Profits Per Employee	-40.82M
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.55% in the last 52 weeks. The beta is 0.29, so Biosergen AB's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-13.55%
50-Day Moving Average	41.05
200-Day Moving Average	47.96
Relative Strength Index (RSI)	33.27
Average Volume (20 Days)	1,301

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.86M
Pretax Income	-40.82M
Net Income	-40.82M
EBITDA	n/a
EBIT	-40.86M
Earnings Per Share (EPS)	-17.38

Full Income Statement

Balance Sheet

The company has 15.37 million in cash and n/a in debt, giving a net cash position of 15.37 million or 6.54 per share.

Cash & Cash Equivalents	15.37M
Total Debt	n/a
Net Cash	15.37M
Net Cash Per Share	6.54
Equity (Book Value)	8.12M
Book Value Per Share	3.46
Working Capital	10.48M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-35.53M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biosergen AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.13%
Shareholder Yield	2.13%
Earnings Yield	-46.98%
FCF Yield	n/a

Stock Splits

The last stock split was on December 1, 2025. It was a reverse split with a ratio of 0.01.

Last Split Date	Dec 1, 2025
Split Type	Reverse
Split Ratio	0.01

Scores

Altman Z-Score	n/a
Piotroski F-Score	1